http://www.tradingmarkets.com/.site/news/Stock%20News/902291/
<p>By Fain Hughes, Dec. 11, 2007 (TradingMarkets.com)- Cyberkinetics Neurotechnology Systems, Inc. (CYKN) has received a letter from the FDA requesting additional analyses and data regarding its Humanitarian Device Exemption (HDE) marketing application for the Andara(TM) OFS(TM) (Oscillating Field Stimulator) System, a nerve growth stimulator designed as a treatment for acute spinal cord injuries. The FDA has identified additional information related to clinical and engineering data that the Company must provide prior to completion of their review of the device. This could result in a delay of approval for the device until at least the first half of 2008…</p>